MAXIGRATAN-150 (Dabigatran Etexilate 150mg) Capsules: Uses, MOA, Benefits, and Recommended Dosage

  • Post category:Blog
  • Post comments:0 Comments
  • Reading time:8 mins read
Dabigatran Etexilate 150mg Capsules: Uses, MOA, Benefits, and Dosage


MAXIGRATAN-150 Capsules, containing Dabigatran Etexilate, represent a cutting-edge approach to anticoagulation therapy, offering improved safety and efficacy in preventing thromboembolic events.

Mechanism of Action (MOA):

Dabigatran Etexilate inhibits thrombin, a key enzyme in the coagulation cascade, thereby preventing the formation of blood clots. By targeting thrombin directly, it offers a more predictable anticoagulant effect compared to traditional agents like warfarin.

Uses and Benefits:

  1. Stroke Prevention in Atrial Fibrillation (AF): MAXIGRATAN-150 Capsules significantly reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
  2. Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE): These capsules are indicated for the treatment and prevention of recurrent DVT and PE.
  3. Reducing the Risk of Recurrent Venous Thromboembolism (VTE): MAXIGRATAN-150 Capsules help prevent VTE recurrence in patients who have experienced an initial event.

Recommended Dosage:

The recommended dosage of MAXIGRATAN-150 Capsules is 150 mg twice daily, with or without food. Dosage adjustment may be necessary based on renal function and bleeding risk.

Adverse Reactions and Precautions:

  • Side Effects: Common side effects include gastrointestinal symptoms like dyspepsia and gastritis, as well as bleeding events. Monitoring for signs of bleeding and renal function is essential during therapy.
  • Precautionary Measures: MAXIGRATAN-150 Capsules should be used with caution in patients with renal impairment and those at increased risk of bleeding, such as the elderly or individuals on concomitant anticoagulant therapy.


MAXIGRATAN-150 Capsules offer a safer and more convenient alternative to traditional anticoagulants, with a predictable anticoagulant effect and fewer drug interactions. With its proven efficacy in preventing thromboembolic events, it stands as a cornerstone in the management of various cardiovascular conditions.

Related Combinations:

Explore other cardiovascular medications and combination therapies offered by Invision Medi Sciences to address various aspects of heart health and hypertension management.

Safeguarding Hearts, Protecting Lives with MAXIGRATAN-150 Capsules


What is Dabigatran Etexilate, and how does it differ from traditional anticoagulants?

Dabigatran Etexilate is a novel oral anticoagulant that directly inhibits thrombin, a crucial enzyme in the blood clotting process. Unlike traditional anticoagulants like warfarin, it offers a more predictable anticoagulant effect and does not require routine monitoring of blood levels.

How often do I need to take MAXIGRATAN-150 Capsules?

MAXIGRATAN-150 Capsules are typically taken twice daily, with or without food. It’s important to follow your healthcare provider’s instructions regarding dosage and timing to ensure optimal efficacy and safety.

What should I do if I miss a dose of MAXIGRATAN-150 Capsules?

If you miss a dose, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not double the dose to catch up.

Are there any dietary restrictions or interactions to be aware of while taking MAXIGRATAN-150 Capsules?

Dabigatran Etexilate is less affected by dietary factors compared to warfarin. However, it’s essential to avoid excessive consumption of foods rich in vitamin K, as they may interfere with the anticoagulant effect. Additionally, inform your healthcare provider about any other medications, supplements, or herbal products you are taking to avoid potential interactions.

What precautions should I take while using MAXIGRATAN-150 Capsules?

It’s crucial to adhere to your prescribed dosage regimen and attend regular follow-up appointments with your healthcare provider for monitoring. Report any signs of unusual bleeding, such as frequent nosebleeds or blood in the urine, immediately. Be cautious when participating in activities that carry a risk of injury, and inform medical personnel about your anticoagulant therapy in case of emergencies.

Leave a Reply

The reCAPTCHA verification period has expired. Please reload the page.